Life Sciences

Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.

Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.

Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.

We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.

Our Latest thinking

EY Biotech Beyond Borders Report 2025

Biotech companies and life sciences leaders are managing uncertainty and preparing to bounce back across the biotechnology landscape. Find out how.

How biopharma can get the right mix of people and tech for launch success

Facing a challenging commercial environment, biopharma companies need to embrace an end-to-end, AI-driven strategy to succeed. Read more.

Daniel Mathews + 1

Pulse of the MedTech Industry Report

EY MedTech report on dealmaking, financing and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.

John Babitt + 1

Why licensing deals are a powerful source of growth in life sciences

Innovation is key in Life Sciences. In response to challenges, pharmaceutical companies increasingly turn to external innovation, leveraging licensing deals. Learn more.

Dr. Markus von Minden + 1

How will you respond to clinicians sounding the alarm on unsustainable care delivery models?

The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.

How innovation can unlock the power of data to deliver value-based care

Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future. Learn more.

Pamela Spence

Life Sciences 4.0

When the human body is the biggest data platform, who will capture value?

Learn more

Pharma promotional content management services

The EY Promotional Content Management Services team can provide you with support that will transform your processes and improve your results. Learn more.
Read more
EY Smart Reviewer

The EY Smart Reviewer can help your business accelerate and optimize the review and approval process for marketing and promotional materials. Find out how.
Read more
Biopharma launch services

Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more
EY Health Outcomes Platform

The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more
Field-force behavioral benchmarking services

Our Field-force Behavioral Benchmarking team can help your business achieve improved commercial performance. Find out how.
Read more
EY Biotech Beyond Borders Report 2025

Biotech companies and life sciences leaders are managing uncertainty and preparing to bounce back across the biotechnology landscape. Find out how.
Read more
Pulse of the MedTech Industry Report

EY MedTech report on dealmaking, financing and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.
Read more

Maarten Moreels

EY-Parthenon Belgium Partner; EY Belgium Life Sciences Leader

Commercial strategy & Pricing leader. Converting strategy into higher profitability. Creating long-term value. Growth by commercial excellence. Hiker & cycling fan. Traveler and Italian wine lover.

Diegem, Belgium

On the agenda (3)

Skip

west

Life Sciences 4.0: securing value through data-driven platforms

Life Sciences 4.0: securing value through data-driven platforms

Public policy

Featured: How to navigate global trends in Artificial Intelligence regulation

Health

Featured: How US trade and EU austerity could force EU pharma to rewrite its playbook

east

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.